original ) (raw )Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
Robert Bonomo
Clinical Infectious Diseases, 2016
View PDFchevron_right
Multiple-dose pharmacokinetics of ceftazidime in cancer patients
H. Lode
Antimicrobial Agents and Chemotherapy, 1983
View PDFchevron_right
Clinical profile of patients treated with cefepime/tazobactam: A new ß-lactam/ß-lactamase inhibitor combination
Ashwini Tayade
Journal of Microbiology and Infectious Diseases, 2012
View PDFchevron_right
Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?
Jeffrey Lipman
The Journal of antimicrobial chemotherapy, 2015
View PDFchevron_right
Is continuous infusion of β-lactam antibiotics worthwhile?—efficacy and pharmacokinetic considerations
Alexander Vinks
Journal of Antimicrobial Chemotherapy, 1996
View PDFchevron_right
Pharmacodynamics of cefepime in patients with Gram-negative infections
Peggy McKinnon
Journal of Antimicrobial Chemotherapy, 2002
View PDFchevron_right
Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study
Ilker Uckay
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2017
View PDFchevron_right
Continuous infusion of β-lactam antibiotics in severe infections: a review of its role
Jennifer Paratz
International Journal of Antimicrobial Agents, 2007
View PDFchevron_right
Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures
Brett McWhinney
The Journal of antimicrobial chemotherapy, 2018
View PDFchevron_right
Pharmacokinetics of beta-lactam antibiotics in patients with intra-abdominal disease: A structured review
Sunil Kumar
2012
View PDFchevron_right
Improved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitro
Murray Barclay
Antimicrobial Agents and Chemotherapy, 1995
View PDFchevron_right
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol-An All-Inclusive Guide for Clinicians
Giacomo Stroffolini , Giuliana Decorti , Lilia Andriani , Marina Steyde , Stefano Di Bella
View PDFchevron_right
I N V I Pharmacokinetic and Pharmacodynamic Issues for Antimicrobial Therapy in Patients With Cancer
Ursula Theuretzbacher
View PDFchevron_right
Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model
María-José Giménez
Journal of Antimicrobial Chemotherapy, 2005
View PDFchevron_right
In Vitro Activity of Ceftazidime, Cefotaxime and Gentamicin Against 11,521 Clinical Isolates of Bacteria
M. Steinbakk
Acta Pathologica Microbiologica Scandinavica Series B: Microbiology, 2009
View PDFchevron_right
Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-Abdominal Infections, Complicated Urinary Tract Infections and Nosocomial Pneumonia
Wright W Nichols
Antimicrobial Agents and Chemotherapy
View PDFchevron_right
Simultaneous determination of seven β-lactam antibiotics in human plasma for therapeutic drug monitoring and pharmacokinetic studies
Thomas Robertson
Journal of Chromatography B, 2014
View PDFchevron_right
β-lactam antibiotic concentrations during continuous renal replacement therapy
Maya Hites , Lucie Seyler
Critical care (London, England), 2014
View PDFchevron_right
Continuous infusion of beta-lactam antibiotics
Nicholas Adomakoh
Antimicrobial Agents and Chemotherapy, 1992
View PDFchevron_right
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients
Jeffrey Lipman
2014
View PDFchevron_right
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Avibactam Alone and in Combination with Ceftazidime in Healthy Male Volunteers: Results of Two Randomized, Placebo-Controlled Studies
Manickam Rangaraju
Clinical drug investigation, 2015
View PDFchevron_right
Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients
Karen Bush
Antimicrobial Agents and Chemotherapy, 1992
View PDFchevron_right
Activity of cefepime against ceftazidime- and cefotaxime-resistant Gram-negative bacteria and its relationship to β-lactamase levels
Frank DeOrio
Antimicrobial Agents and Chemotherapy, 1989
View PDFchevron_right
Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers
E. Prens
Antimicrobial Agents and Chemotherapy, 1990
View PDFchevron_right
Better Outcome of High-Dose Ceftazidime in Hemato – Oncological Patients with Infections Caused by Extensively Drug-Resistant Pseudomonas Aeruginosa
Pavla Paterova
Mediterranean Journal of Hematology and Infectious Diseases
View PDFchevron_right
Bactericidal activity, absence of serum effect, and time-kill kinetics of ceftazidime-avibactam against β-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa
Wright W Nichols
Antimicrobial agents and chemotherapy, 2014
View PDFchevron_right
Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients—A Narrative Review
Markéta Škardová
Antibiotics
View PDFchevron_right
Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms
B. Gordts
Antimicrobial Agents and Chemotherapy, 1983
View PDFchevron_right
Effect of Treatment Duration on Pharmacokinetic/Pharmacodynamic Indices Correlating with Therapeutic Efficacy of Ceftazidime in Experimental Klebsiella pneumoniae Lung Infection
Wil Goessens
Antimicrobial Agents and Chemotherapy, 2006
View PDFchevron_right
Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients
Milan Kaska
Biomedical Papers
View PDFchevron_right
Clinical Pharmacology of Antibiotics
Kristina Shvets
Clinical Journal of the American Society of Nephrology
View PDFchevron_right
Analysis of Two Cephalosporin Drugs Ceftriaxone and Cefepime Alone and in Presence of Two β-Lactamase Inhibitors Sulbactam and Tazobactam
BN Sinha
Asian Journal of Chemistry
View PDFchevron_right
Potentiation of ceftazidime by avibactam against β-lactam-resistantPseudomonas aeruginosain anin vitroinfection model
Wright W Nichols
Journal of Antimicrobial Chemotherapy
View PDFchevron_right